Document Detail


Scar thinning due to ibuprofen administration after experimental myocardial infarction.
MedLine Citation:
PMID:  6829446     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although much attention has been directed toward interventions which reduce myocardial infarct size, the effect of such agents on the healing phase of myocardial infarction is not well understood. The present study examines the effect of the nonsteroidal anti-inflammatory agent ibuprofen, previously demonstrated to be able to reduce infarct size, and of aspirin on the healing of experimentally produced myocardial infarcts. Thirty-nine anesthetized, open-chest dogs were subjected to proximal left anterior descending coronary artery occlusions for 6 weeks. Four groups of dogs were studied: (1) a control (untreated) group: (2) ibuprofen, 12.5 mg/kg intravenously 15 minutes and 6, 12, 18, and 24 hours after occlusion (high dose); (3) ibuprofen, 12.5 mg/kg intravenously 15 minutes and 3 hours after occlusion (low dose); (4) aspirin, 30 mg/kg intravenously 15 minutes and 3 hours after occlusion. The average thickness of the transmural scar and of the noninfarcted left ventricular wall was determined from multiple measurements of formalin-fixed left ventricular slices. The ratio of transmural scar to noninfarcted wall thickness was determined. In control animals the ratio was 0.87 with only 1 of 15 animals having a ratio less than 0.60. High-dose ibuprofen-treated animals had an average ratio of 0.59 (difference not significant [NS] compared with control values), with 6 of 9 animals having a ratio less than 0.60 (p less than 0.02 compared with control values). Low-dose ibuprofen-treated animals had an average ratio of 0.66 (p less than 0.05 compared with control values), with 4 of 8 animals having a ratio less than 0.60 (p = NS compared with control values). In the aspirin-treated animals, the ratio was 0.88 (p = NS compared with control values), with 0 of 7 animals having a ratio less than 0.60 (p = NS compared with control values). Although 1 of 22 animals had ratios less than 0.60 in the control and aspirin groups, 10 of 17 had ratios less than 0.60 in the ibuprofen-treated groups (p less than 0.001). Scars in treated animals did not differ from those in control animals histologically or by analysis of hydroxyproline content per unit weight. Thus, ibuprofen, a nonsteroidal anti-inflammatory agent which reduces infarct size, is shown to increase the incidence of scar thinning after myocardial infarction.
Authors:
E J Brown; R A Kloner; F J Schoen; H Hammerman; S Hale; E Braunwald
Related Documents :
6693646 - Effect of decreased blood flow and ischemia on myocardial thallium clearance.
3826686 - Isoflurane causes regional myocardial dysfunction in dogs with critical coronary artery...
22225626 - Dose-dependent functional benefit of human cardiosphere transplantation in mice with ac...
2742326 - Hemodynamic and electrophysiologic effects of low osmolar contrast agents during corona...
436516 - Historic and angiographic features of young adults surviving myocardial infarction.
18402716 - Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within t...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of cardiology     Volume:  51     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1983 Mar 
Date Detail:
Created Date:  1983-04-07     Completed Date:  1983-04-07     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  877-83     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aspirin / therapeutic use
Dogs
Female
Hydroxyproline / metabolism
Ibuprofen / therapeutic use*
Male
Myocardial Infarction / drug therapy*,  metabolism,  pathology
Myocardium / metabolism,  pathology*
Grant Support
ID/Acronym/Agency:
HL-23140/HL/NHLBI NIH HHS; HL-26215/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
15687-27-1/Ibuprofen; 50-78-2/Aspirin; 51-35-4/Hydroxyproline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Topographic changes in the left ventricle after experimentally induced myocardial infarction in the ...
Next Document:  Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: reduction or delay?